Haw Par Corporation Limited (HAWPY)
Haw Par Corporation Limited operates in the Drug Manufacturers - General industry of the Healthcare sector, headquartered in Singapore, NW, SG. The stock last traded at $53.50, up 0.00% on the session, giving a market capitalisation of $2.96B. On trailing twelve-month figures it carries a trailing P/E of 12.71, a net margin of 104.4%. Its beta of 0.17 implies it has historically moved less than the broad market.
Haw Par Corporation Limited, through its numerous subsidiaries, engages in the creation, distribution, and sale of healthcare products across Singapore, the ASEAN region, other Asian nations, and internationally. Its business is structured into three main divisions: Healthcare, Investments, and a general "Others" category. The Healthcare segment's primary focus is on manufacturing and supplying topical analgesic remedies, notably the prominent Tiger Balm and Kwan Loong brands. The Investments division concentrates predominantly on financial investments, specifically in publicly listed securities. Additionally, the company manages and rents out a substantial portfolio of investment properties, offering 45,324 square meters of commercial and industrial space in Singapore and Malaysia. It also provides family-oriented and tourist leisure options, mainly through its oceanariums. Furthermore, Haw Par Corporation leases land, buildings, and office spaces, and extends management support services. The company was founded in Singapore in 1969 and continues to operate from its base there.
Haw Par Corporation Limited is most often compared with the following Healthcare names: